colchicine has been researched along with Stroke in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (21.05) | 24.3611 |
| 2020's | 30 (78.95) | 2.80 |
| Authors | Studies |
|---|---|
| Budhathoki, P; Elgendy, I; Khadka, M; Mir, WAY; Patel, NK; Patel, T; Pokharel, S; Sedhai, Y; Shrestha, DB; Yadav, S | 1 |
| Lin, Z; Liu, H; Mao, L; Xu, H; Yang, J; Zhang, Y | 1 |
| Huang, D; Liang, H | 1 |
| Itokazu, T; Shibuya, N; Ueda, T; Yamashita, T | 1 |
| Attar, A; Kazemi, A; Ramezani, A; Razavi, E | 1 |
| Chan, BPL; Goh, CXY; Goh, S; Ho, AFW; Ho, JSY; Leow, AST; Sharma, VK; Tan, BYQ; Tan, CH; Tan, NHW; Tan, YK; Yeo, LLL | 1 |
| Hsu, CY; Hsueh, MY; Kao, CH; Kuo, IL; Yeh, JJ; Yip, HT | 1 |
| Bao, YL; Du, C; Gu, LF; Wang, LS; Wang, YX | 1 |
| Chang, L; Jing, J; Li, H; Li, J; Meng, X; Niu, S; Wang, A; Wang, Y; Xie, X; Yuan, B | 1 |
| Castilla-Guerra, L; Fernandez-Moreno, MC; Jiménez-Hernández, MD; Rico-Corral, MÁ | 1 |
| Johansen, NJ; Knop, FK | 1 |
| Acar-Ozen, P; Akbaba, TH; Arsava, EM; Ayvacioglu-Cagan, C; Balcı-Peynircioğlu, B; Gocmen, R; Kalyoncu, U; Topcuoglu, MA; Tuncer, MA | 1 |
| Ahmad, R; Archer, H; Cambi, B; Cleman, M; Dela Cruz, C; Howes, C; Huang, H; Kandel, P; Kashyap, N; Khan, M; Kluger, J; Lancaster, G; Lansky, A; Lu, J; McCarthy, M; Nasir, I; Paredes, C; Parise, H; Patel, P; Ragheb, E; Shah, T; Song, C; Ul Haq, F | 1 |
| Hao, J; Mu, Y; Tan, L; Wang, S | 1 |
| De Sarro, G; Gallelli, L; Lochner, P; Siniscalchi, A | 1 |
| Cai, X; Hu, S; Ji, L; Li, Z; Lin, C; Lv, F; Yang, W; Zhu, X | 1 |
| Bax, WA; Budgeon, CA; Cornel, JH; Eikelboom, JW; Fiolet, ATL; Mosterd, A; Nidorf, SM; Opstal, TSJ; Schut, A; Thompson, PL; Tijssen, JGP | 1 |
| Angoulvant, D; Berry, C; Bertrand, OF; Blondeau, L; Diaz, R; Dubé, MP; Gamra, H; Grégoire, JC; Guertin, MC; Ibrahim, R; Kiwan, GS; Koenig, W; Kouz, S; L'Allier, PL; Lavoie, MA; López-Sendón, J; Maggioni, AP; Orfanos, A; Ostadal, P; Pinto, FJ; Provencher, M; Rhainds, D; Roubille, F; Tardif, JC; Waters, DD | 1 |
| Georgakis, MK; Giannopoulos, S; Katsanos, AH; Kelly, PJ; Kosmidou, M; Lemmens, R; Palaiodimou, L; Price, C; Tsivgoulis, G; Weimar, C | 1 |
| Lavalle-Cobo, A; Lobo, M; Masson, G; Masson, W; Molinero, G | 1 |
| Andersen, ML; Finsterer, J; Oliveira, LF; Rodrigues, LD; Scorza, CA; Scorza, FA; Tufik, S | 1 |
| Chan, JSK | 1 |
| Caso, V; Mas, JL | 1 |
| Fischman, D; Gowda, SN; Ullah, W | 1 |
| Berry, C; Bertrand, OF; Blondeau, L; Bouabdallaoui, N; Diaz, R; Dubé, MP; Gamra, H; Grégoire, JC; Guertin, MC; Ibrahim, R; Kiwan, GS; Koenig, W; Kouz, S; L'Allier, PL; Lim, P; Lopez-Sendon, J; Maggioni, AP; Morel, O; Orfanos, A; Pinto, FJ; Roubille, F; Samuel, M; Tardif, JC; Waters, DD | 1 |
| Abdel-Latif, A; Abo-Aly, M; Shindo, K; Shokri, E; Wudexi, I | 1 |
| Budgeon, C; Cornel, JH; Eikelboom, JW; Fiolet, ATL; Jolly, SS; Keech, AC; Kelly, P; Layland, J; Mosterd, A; Nidorf, SM; Opstal, TSJ; Thompson, PL; Tijssen, JGP; Tong, DC | 1 |
| Andreis, A; Avondo, S; Casula, M; De Ferrari, GM; Imazio, M; Paneva, E; Piroli, F | 1 |
| Imazio, M; Nidorf, M | 1 |
| Kelly, PJ; Lemmens, R; Tsivgoulis, G | 1 |
| Bajraktari, G; Banach, M; Bytyçi, I; Henein, MY; Penson, PE | 1 |
| Bax, WA; Budgeon, CA; Cornel, JH; den Hartog, F; Duyvendak, M; Eikelboom, JW; El Messaoudi, S; Fiolet, ATL; Mosterd, A; Nidorf, SM; Opstal, TSJ; Thompson, PL; Tijssen, JGP; van Beek, EA; van Broekhoven, A; van Eck, JWM | 1 |
| Coveney, S; Kelly, PJ; Lemmens, R; Murphy, S; Price, C; Purroy, F; Tsivgoulis, G | 1 |
| Drosos, E; Giakoumettis, D; Themistocleous, MS | 1 |
| Khandkar, C; Patel, S; Vaidya, K | 1 |
| Alves, C; Carballo, S; Darbellay, P; Lebowitz, D; Moret, M; Sabeh, N | 1 |
| Arpagaus, A; Briel, M; Ewald, H; Glinz, D; Gloy, VL; Hemkens, LG; Nidorf, M; Nordmann, AJ; Olu, KK | 1 |
| Eikelboom, JW; Fagel, ND; Hiralal, R; Nidorf, M; Raju, NC; Yi, Q | 1 |
22 review(s) available for colchicine and Stroke
| Article | Year |
|---|---|
Colchicine for Patients With Coronary Artery Disease: A Systematic Review and Meta-analysis.
Topics: Anti-Inflammatory Agents; Colchicine; Coronary Artery Disease; Humans; Myocardial Infarction; Stroke | 2022 |
Colchicine for Secondary Prevention of Coronary Artery Disease: A Meta-Analysis of Randomised Controlled Trials.
Topics: Anti-Inflammatory Agents; Colchicine; Coronary Artery Disease; Humans; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke | 2022 |
Comment on "Efficacy and safety of colchicine in patients with coronary artery disease: A systematic review and meta-analysis of randomized controlled trials".
Topics: Colchicine; Coronary Artery Disease; Humans; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke | 2022 |
Effect of Treatment with Colchicine after Acute Coronary Syndrome on Major Cardiovascular Events: A Systematic Review and Meta-Analysis of Clinical Trials.
Topics: Acute Coronary Syndrome; C-Reactive Protein; Colchicine; Humans; Myocardial Infarction; Stroke | 2022 |
The use of colchicine as an anti-inflammatory agent for stroke prevention in patients with coronary artery disease: a systematic review and meta-analysis.
Topics: Anti-Inflammatory Agents; Colchicine; Coronary Artery Disease; Humans; Myalgia; Stroke | 2022 |
Evaluating the Utility of Colchicine in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis.
Topics: Acute Coronary Syndrome; Cause of Death; Colchicine; Humans; Myocardial Infarction; Stroke | 2022 |
Acute stroke in familial Mediterranean fever: An analysis of 23 new cases and systematic review of the literature.
Topics: Colchicine; Familial Mediterranean Fever; Humans; Ischemic Stroke; Risk Factors; Stroke | 2023 |
Efficacy and Safety of Different Dosing Regimens of Colchicine in Patients With Coronary Artery Disease: A Network Meta-analysis of 15 Randomized Controlled Trials.
Topics: Colchicine; Coronary Artery Disease; Humans; Network Meta-Analysis; Randomized Controlled Trials as Topic; Stroke | 2023 |
Anti-inflammatory therapies were associated with reduced risk of myocardial infarction in patients with established cardiovascular disease or high cardiovascular risks: A systematic review and meta-analysis of randomized controlled trials.
Topics: Aged; Anti-Inflammatory Agents; Cardiovascular Diseases; Colchicine; Heart Failure; Humans; Interleukin-1; Interleukin-6; Myocardial Infarction; Randomized Controlled Trials as Topic; Stroke | 2023 |
Colchicine for stroke prevention in patients with coronary artery disease: a systematic review and meta-analysis.
Topics: Colchicine; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Secondary Prevention; Stroke | 2020 |
Role of Colchicine in Stroke Prevention: An Updated Meta-Analysis.
Topics: Anti-Inflammatory Agents; Colchicine; Humans; Incidence; Myocardial Infarction; Protective Factors; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Stroke; Time Factors; Treatment Outcome | 2020 |
Safety and Efficacy of Colchicine in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis.
Topics: Acute Coronary Syndrome; Colchicine; Coronary Artery Disease; Humans; Stents; Stroke | 2021 |
Comparative Effectiveness of Anti-Inflammatory Drug Treatments in Coronary Heart Disease Patients: A Systematic Review and Network Meta-Analysis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Colchicine; Comparative Effectiveness Research; Coronary Circulation; Female; Follow-Up Studies; Heart Diseases; Humans; Male; Middle Aged; Myocardial Infarction; Network Meta-Analysis; Randomized Controlled Trials as Topic; Stroke; Treatment Outcome | 2021 |
Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials.
Topics: Colchicine; Coronary Artery Disease; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Stroke; Treatment Outcome | 2021 |
Efficacy and safety of colchicine for the prevention of major cardiovascular and cerebrovascular events in patients with coronary artery disease: a systematic review and meta-analysis on 12 869 patients.
Topics: Colchicine; Coronary Artery Disease; Humans; Myocardial Infarction; Secondary Prevention; Stroke | 2022 |
Colchicine and the heart.
Topics: Anti-Inflammatory Agents; Brain Ischemia; Colchicine; Humans; Pericarditis; Stroke | 2021 |
Inflammation and Stroke Risk: A New Target for Prevention.
Topics: Animals; Anti-Inflammatory Agents; Colchicine; Drug Delivery Systems; Gout Suppressants; Humans; Inflammation; Mendelian Randomization Analysis; Observational Studies as Topic; Risk Factors; Secondary Prevention; Stroke | 2021 |
Efficacy and safety of colchicine in patients with coronary artery disease: A systematic review and meta-analysis of randomized controlled trials.
Topics: C-Reactive Protein; Colchicine; Coronary Artery Disease; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Stroke; Treatment Outcome | 2022 |
Anti-inflammatory approaches to ischaemic stroke prevention.
Topics: Anti-Inflammatory Agents; Brain Ischemia; C-Reactive Protein; Colchicine; Coronary Disease; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Intracranial Arteriosclerosis; Plaque, Atherosclerotic; Recurrence; Stroke | 2018 |
Colchicine in Neurosurgery.
Topics: Colchicine; Glioma; Gout Suppressants; Humans; Low Back Pain; Neurosurgery; Stroke | 2018 |
Colchicine for Stroke Prevention: A Systematic Review and Meta-analysis.
Topics: Cohort Studies; Colchicine; Humans; Ischemic Attack, Transient; Protective Agents; Randomized Controlled Trials as Topic; Stroke | 2019 |
Colchicine for prevention of cardiovascular events.
Topics: Anti-Inflammatory Agents; Cardiovascular Diseases; Cause of Death; Colchicine; Heart Failure; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Risk; Stroke | 2016 |
7 trial(s) available for colchicine and Stroke
| Article | Year |
|---|---|
Effect of different doses of colchicine on high sensitivity C-reactive protein in patients with acute minor stroke or transient ischemic attack: A pilot randomized controlled trial.
Topics: C-Reactive Protein; Colchicine; Humans; Ischemic Attack, Transient; Ischemic Stroke; Pilot Projects; Platelet Aggregation Inhibitors; Stroke | 2022 |
Colchicine and high-intensity rosuvastatin in the treatment of non-critically ill patients hospitalised with COVID-19: a randomised clinical trial.
Topics: Brain Ischemia; Colchicine; COVID-19; Female; Humans; Male; Middle Aged; Rosuvastatin Calcium; SARS-CoV-2; Stroke; Treatment Outcome | 2023 |
The effect of low-dose colchicine in patients with stable coronary artery disease: The LoDoCo2 trial rationale, design, and baseline characteristics.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Atherosclerosis; Australia; Cardiovascular Diseases; Clinical Trial Protocols as Topic; Colchicine; Coronary Artery Disease; Double-Blind Method; Drug Administration Schedule; Drug Repositioning; Female; Humans; Male; Middle Aged; Myocardial Infarction; Netherlands; Percutaneous Coronary Intervention; Secondary Prevention; Stroke; Tubulin Modulators | 2019 |
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.
Topics: Aged; Angina Pectoris; Anti-Inflammatory Agents; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Colchicine; Double-Blind Method; Female; Humans; Incidence; Intention to Treat Analysis; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Proportional Hazards Models; Recurrence; Stroke | 2019 |
Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT).
Topics: Angina Pectoris; Colchicine; Humans; Myocardial Infarction; Stroke; Time-to-Treatment; Treatment Outcome | 2020 |
Colchicine in Patients With Chronic Coronary Disease in Relation to Prior Acute Coronary Syndrome.
Topics: Acute Coronary Syndrome; Colchicine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Monitoring; Female; Gout Suppressants; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Outcome Assessment, Health Care; Risk Assessment; Secondary Prevention; Stroke; Time-to-Treatment | 2021 |
Effect of colchicine compared with placebo on high sensitivity C-reactive protein in patients with acute coronary syndrome or acute stroke: a pilot randomized controlled trial.
Topics: Acute Coronary Syndrome; Aged; Biomarkers; C-Reactive Protein; Colchicine; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pilot Projects; Stroke | 2012 |
9 other study(ies) available for colchicine and Stroke
| Article | Year |
|---|---|
Intravital Imaging Reveals the Ameliorating Effect of Colchicine in a Photothrombotic Stroke Model via Inhibition of Neutrophil Recruitment.
Topics: Animals; Colchicine; Infarction; Intravital Microscopy; Mice; Neutrophil Infiltration; Neutrophils; Stroke | 2023 |
Effects of colchicine use on ischemic and hemorrhagic stroke risk in diabetic patients with and without gout.
Topics: Colchicine; Diabetes Mellitus; Gout; Hemorrhagic Stroke; Humans; Ischemic Stroke; Retrospective Studies; Stroke | 2022 |
Colchicine in stroke prevention. Is it time to change our clinical practice?
Topics: Colchicine; Humans; Stroke | 2023 |
The potential of colchicine for lowering the risk of cardiovascular events in type 1 diabetes.
Topics: Atherosclerosis; Brain Ischemia; Colchicine; Diabetes Mellitus, Type 1; Humans; Inflammation; Stroke | 2023 |
Is Colchicine Involved in Managing Stroke?
Topics: Colchicine; Humans; Myocardial Infarction; Stroke | 2023 |
We never speak about sudden unexpected death in Parkinson's disease.
Topics: Colchicine; Coronary Artery Disease; Death, Sudden; Humans; Parkinson Disease; Stroke | 2020 |
Colchicine prevents stroke in patients with coronary artery disease - a trial sequential analysis.
Topics: Colchicine; Coronary Artery Disease; Humans; Stroke | 2020 |
Optimization of stroke prevention: colchicine may be an option.
Topics: Colchicine; Coronary Artery Disease; Humans; Stroke | 2020 |
[Internal medicine in the hospital setting].
Topics: Adrenergic beta-Antagonists; Aminobutyrates; Angiotensin Receptor Antagonists; Asymptomatic Diseases; Atrial Fibrillation; Biphenyl Compounds; Carotid Stenosis; Colchicine; Diuretics; Drug Combinations; Heart Failure; Hospitals; Humans; Internal Medicine; Liver Cirrhosis; Narcotics; Neprilysin; Pericarditis; Peritonitis; Pulmonary Disease, Chronic Obstructive; Respiratory Therapy; Spironolactone; Stroke; Tetrazoles; Valsartan | 2015 |